CME Group Inc. 8-K Summary: 2026 Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Shareholders held by CME Group Inc. on May 14, 2026. The report details voting outcomes for director elections, auditor ratification, and executive compensation. The record date for the meeting was March 16, 2026, with 362,808,081 shares of Class A and Class B common stock issued and outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Outcomes
- Quorum Status: While Class A and Class B shareholders collectively achieved an 87.78% attendance rate, specific Class B series (B-1, B-2, B-3, and B-4) failed to reach the required 33.3% quorum threshold individually.
- Adjournment: Due to the lack of quorum for Class B shareholders, proposals Items 4 through 8 were adjourned to a virtual meeting scheduled for June 9, 2026.
- Director Elections: All 14 Equity Director nominees were elected to serve until the 2027 annual meeting. Votes were cast by Class A and Class B shareholders as a single class.
- Auditor Ratification: The appointment of Ernst & Young LLP as the independent auditor for 2026 was approved.
- Executive Compensation: The advisory proposal to approve the compensation of named executive officers was approved.
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, outlook, or specific risks. The primary contingency noted is the rescheduling of specific shareholder proposals to June 9, 2026, due to insufficient participation from Class B shareholders.
Key Facts for Investor Verification
- Verify the specific content of the adjourned proposals (Items 4 through 8) in the definitive proxy statement filed on March 23, 2026.
- Confirm the outcome of the adjourned meeting scheduled for June 9, 2026.
- Note the significant "Against" votes for certain directors, specifically Martin J. Gepsman (52,090,523 against) and Charles P. Carey (41,546,896 against), despite their election.
- Review the total broker non-votes of 23,505,825 recorded for the director election and executive compensation proposals.